Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Bonnet

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Pharmacology & Physiology|June 5, 1998
Vasorelaxant effects of SCA40 (a phosphodiesterase III inhibitor) in pulmonary vascular preparations in ratsT K Crilley, J C Wanstall, P A Bonnet
Biochemical Pharmacology|April 25, 1997
Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell lineK Zurbonsen, A Michel, D Vittet, et al.
Biochemical Pharmacology|August 1, 1997
Antiproliferative effects of imidazo[1,2-a]pyrazine derivatives on the Dami cell lineK Zurbonsen, A Michel, D Vittet, et al.
Pharmacology & Toxicology|June 1, 1997
Modulation of the megakaryoblastic Dami cell line differentiation by phosphodiesterase inhibitors and imidazo[1,2-a]pyrazine derivativesK Zurbonsen, A Michel, D Vittet, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|December 14, 2011
Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detectionH Rebiere, P Guinot, C Civade, et al.
General Pharmacology|January 15, 1999
Antiproliferative, differentiating and apoptotic effects elicited by imidazo[1,2-a]pyrazine derivativesK Zurbonsen, A Michel, P A Bonnet, et al.
The Journal of Pharmacy and Pharmacology|November 1, 1992
Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic ratsA Michel, P A Bonnet, J P Fernandez, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1989
Pharmacokinetic study of tempo carboxylic acid, a nitroxyl MRI contrast media, in control and streptozocin diabetic ratsA Michel, J P Fernandez, G Subra, et al.
Pharmeuropa Scientific Notes|August 19, 2007
In vitro pyrogenicity of Gram-positive bacteria--validation of the kit using fresh human whole bloodC François, J Neveu, D Sauvaire, et al.
Arzneimittel-Forschung|December 1, 1995
Pharmacological activities of imidazo[1,2-alpha]pyrazine derivativesA Michel, F Laurent, J P Chapat, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Pharmacology & Physiology|June 5, 1998
Vasorelaxant effects of SCA40 (a phosphodiesterase III inhibitor) in pulmonary vascular preparations in ratsT K Crilley, J C Wanstall, P A Bonnet
Biochemical Pharmacology|April 25, 1997
Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell lineK Zurbonsen, A Michel, D Vittet, et al.
Biochemical Pharmacology|August 1, 1997
Antiproliferative effects of imidazo[1,2-a]pyrazine derivatives on the Dami cell lineK Zurbonsen, A Michel, D Vittet, et al.
Pharmacology & Toxicology|June 1, 1997
Modulation of the megakaryoblastic Dami cell line differentiation by phosphodiesterase inhibitors and imidazo[1,2-a]pyrazine derivativesK Zurbonsen, A Michel, D Vittet, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|December 14, 2011
Detection of hazardous weight-loss substances in adulterated slimming formulations using ultra-high-pressure liquid chromatography with diode-array detectionH Rebiere, P Guinot, C Civade, et al.
General Pharmacology|January 15, 1999
Antiproliferative, differentiating and apoptotic effects elicited by imidazo[1,2-a]pyrazine derivativesK Zurbonsen, A Michel, P A Bonnet, et al.
The Journal of Pharmacy and Pharmacology|November 1, 1992
Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic ratsA Michel, P A Bonnet, J P Fernandez, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1989
Pharmacokinetic study of tempo carboxylic acid, a nitroxyl MRI contrast media, in control and streptozocin diabetic ratsA Michel, J P Fernandez, G Subra, et al.
Pharmeuropa Scientific Notes|August 19, 2007
In vitro pyrogenicity of Gram-positive bacteria--validation of the kit using fresh human whole bloodC François, J Neveu, D Sauvaire, et al.
Arzneimittel-Forschung|December 1, 1995
Pharmacological activities of imidazo[1,2-alpha]pyrazine derivativesA Michel, F Laurent, J P Chapat, et al.
Pageof 3